ICUD-EAU international consultation on bladder cancer 2012: Urothelial carcinoma of the prostate

European Urology

Volumn 63, Issue 1, 2013, Pages 81-87

  Palou, Juan ^a   Wood, David ^b   Bochner, Bernard H ^c   Van Der Poel, Henk ^d   Al Ahmadie, Hikmat A ^c   Yossepowitch, Ofer ^e   Soloway, Mark S ^f   Jenkins, Lawrence C ^f  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b WILLIAM BEAUMONT HOSPITAL   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d NETHERLANDS CANCER INSTITUTE   (Netherlands)

^e TEL AVIV UNIVERSITY   (Israel)

^f UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Diagnosis; Follow up; Guidelines; Prostate; Recommendations; Treatment; Urothelial cancer

Indexed keywords

BCG VACCINE;

BLADDER CANCER; BLADDER CARCINOMA; CANCER INVASION; CANCER PROGNOSIS; CANCER SURGERY; CYSTOSCOPY; ENDOSCOPIC SURGERY; FOLLOW UP; HUMAN; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE UROTHELIAL CARCINOMA; REVIEW; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION;

ADMINISTRATION, INTRAVESICAL; ANTINEOPLASTIC AGENTS; BCG VACCINE; BIOPSY; CARCINOMA; CHEMOTHERAPY, ADJUVANT; CYSTECTOMY; ENDOSCOPY; HUMANS; MALE; NEOPLASM GRADING; NEOPLASM INVASIVENESS; PREDICTIVE VALUE OF TESTS; PROSTATIC NEOPLASMS; TRANSURETHRAL RESECTION OF PROSTATE; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 84870565122     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2012.08.011     Document Type: Review

References (67)

1. R. Ayyathurai, P. Gomez, T. Luongo, M.S. Soloway, and M. Manoharan Prostatic involvement by urothelial carcinoma of the bladder: clinicopathological features and outcome after radical cystectomy BJU Int 100 2007 1021 1025
2. Phillips B, Ball C, Sackett D, et al. Oxford Centre for Evidence-based Medicine - levels of evidence (March 2009). Centre for Evidence-based Medicine Web site. http://www.cebm.net/index.aspx?o=1025.
3. M.M. Melicow, and J.W. Hollowell Intra-urothelial cancer: carcinoma in situ, Bowen's disease of the urinary system: discussion of thirty cases J Urol 68 1952 763 772
4. L.G. Ortega, W.F. Whitmore, and A.I. Murphy In situ carcinoma of the prostate with intraepithelial extension into the urethra and bladder Cancer 6 1953 898 923
5. T.A. Seemayer, J. Knaack, W.L. Thelmo, N.S. Wang, and M.N. Ahmed Further observations on carcinoma in situ of the urinary bladder: silent but extensive intraprostatic involvement Cancer 36 1975 514 520
6. F. Millan-Rodriguez, G. Chechile-Toniolo, J. Salvador-Bayarri, J. Palou, and J. Vicente-Rodriguez Multivariate analysis of the prognostic factors of primary superficial bladder cancer J Urol 163 2000 73 78
7. W.L. Thelmo, T.A. Seemayer, P. Madarnas, B.M. Mount, and K.J. Mackinnon Carcinoma in situ of the bladder with associated prostatic involvement J Urol 111 1974 491 494
8. P. Bassi BCG (Bacillus of Calmette Guerin) therapy of high-risk superficial bladder cancer Surg Oncol 11 2002 77 83
9. J.W. Davis, S.I. Sheth, M.J. Doviak, and P.F. Schellhammer Superficial bladder carcinoma treated with bacillus Calmette-Guerin: progression-free and disease specific survival with minimum 10-year followup J Urol 167 2002 494 500 discussion 501
10. H.W. Herr, and S.M. Donat Prostatic tumor relapse in patients with superficial bladder tumors: 15-year outcome J Urol 161 1999 1854 1857
11. H.R. Bates Jr. Transitional cell carcinoma of the prostate J Urol 101 1969 206 207
12. A.B. Rubenstein, and M.E. Rubnitz Transitional cell carcinoma of the prostate Cancer 24 1969 543 546
13. J.H. Wolfe, and R.W. Lloyd-Davies The management of transitional cell carcinoma in the prostate Br J Urol 53 1981 253 257
14. D.P. Wood, J.E. Montie, J.E. Pontes, S. VanderBrug Medendorp, and H.S. Levin Transitional cell carcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer J Urol 141 1989 346 349
15. M.U. Mungan, A.E. Canda, E. Tuzel, K. Yorukoglu, and Z. Kirkali Risk factors for mucosal prostatic urethral involvement in superficial transitional cell carcinoma of the bladder Eur Urol 48 2005 760 763
16. R. Mazzucchelli, F. Barbisan, and A. Santinelli Prediction of prostatic involvement by urothelial carcinoma in radical cystoprostatectomy for bladder cancer Urology 74 2009 385 390
17. K.A. Richards, G.E. Parks, G.H. Badlani, A.K. Kader, A.K. Hemal, and J.A. Pettus Developing selection criteria for prostate-sparing cystectomy: a review of cystoprostatectomy specimens Urology 75 2010 1116 1120
18. S.S. Shen, S.P. Lerner, B. Muezzinoglu, L.D. Truong, G. Amiel, and T.M. Wheeler Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance Hum Pathol 37 2006 726 734
19. D. Esrig, J.A. Freeman, and D.A. Elmajian Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion J Urol 156 1996 1071 1076
20. R.G. Nixon, S.S. Chang, B.J. Lafleur, J.A. Smith, and M.S. Cookson Carcinoma in situ and tumor multifocality predict the risk of prostatic urethral involvement at radical cystectomy in men with transitional cell carcinoma of the bladder J Urol 167 2002 502 505
21. F. Barbisan, R. Mazzucchelli, and M. Scarpelli Urothelial and incidental prostate carcinoma in prostates from cystoprostatectomies for bladder cancer: is there a relationship between urothelial and prostate cancer? BJU Int 103 2009 1058 1063
22. D.A. Barocas, S.G. Patel, S.S. Chang, P.E. Clark, J.A. Smith Jr., and M.S. Cookson Outcomes of patients undergoing radical cystoprostatectomy for bladder cancer with prostatic involvement on final pathology BJU Int 104 2009 1091 1097
23. P.F. Schellhammer, M.A. Bean, and W.F. Whitmore Jr. Prostatic involvement by transitional cell carcinoma: pathogenesis, patterns and prognosis J Urol 118 1977 399 403
24. J. Huguet, M. Crego, S. Sabaté, J. Salvador, J. Palou, and H. Villavicencio Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor Eur Urol 48 2005 53 59 discussion 59
25. S.M. Donat, D.C. Wei, M.S. McGuire, and H.W. Herr The efficacy of transurethral biopsy for predicting the long-term clinical impact of prostatic invasive bladder cancer J Urol 165 2001 1580 1584
26. J. Varinot, P. Camparo, and M. Roupret Full analysis of the prostatic urethra at the time of radical cystoprostatectomy for bladder cancer: impact on final disease stage Virchows Archiv 455 2009 449 453
27. E. Solsona, I. Iborra, and J.V. Ricos Recurrence of superficial bladder tumors in prostatic urethra Eur Urol 19 1991 89 92
28. J. Palou, R.J. Sylvester, and O. Rodríguez Faba Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with bacillus Calmette-Guérin Eur Urol 62 2012 118 125
29. S.W. Hardeman, and M.S. Soloway Transitional cell carcinoma of the prostate: diagnosis, staging and management World J Urol 6 1988 170 174
30. C. Wittekind International Union against Cancer. TNM supplement: a commentary on uniform use ed. 3. 2003 Wiley-Liss Hoboken, NJ
31. L.H. Sobin, and C. Wittekind International Union against Cancer. TNM classification of malignant tumours ed. 6. 2002 Wiley-Liss New York, NY
32. E. Orihuela, H.W. Herr, and W.F. Whitmore Jr. Conservative treatment of superficial transitional cell carcinoma of prostatic urethra with intravesical BCG Urology 34 1989 231 237
33. C.H. Rikken, P.J. van Helsdingen, and B.A. Kazzaz Are biopsies from the prostatic urethra useful in patients with superficial bladder carcinoma? Br J Urol 59 1987 145 147
34. A.Z. Weizer, R.B. Shah, and C.T. Lee Evaluation of the prostate peripheral zone/capsule in patients undergoing radical cystoprostatectomy: defining risk with prostate capsule sparing cystectomy Urol Oncol 25 2007 460 464
35. R.W. Hillyard, L. Ladaga, and P.F. Schellhammer Superficial transitional cell carcinoma of the bladder associated with mucosal involvement of the prostatic urethra: results of treatment with intravesical bacillus Calmette-Guerin J Urol 139 1988 290 293
36. P.R. Bretton, H.W. Herr, and W.F. Whitmore Jr. Intravesical bacillus Calmette-Guerin therapy for in situ transitional cell carcinoma involving the prostatic urethra J Urol 141 1989 853 856
37. F. Pagano, P. Bassi, and G.L.D. Ferrante Is stage pT4a (D1) reliable in assessing transitional cell carcinoma involvement of the prostate in patients with a concurrent bladder cancer? A necessary distinction for contiguous or noncontiguous involvement J Urol 155 1996 244 247
38. J.A. Pettus, H. Al-Ahmadie, and D.A. Barocas Risk assessment of prostatic pathology in patients undergoing radical cystoprostatectomy Eur Urol 53 2008 370 375
39. J. Arce, J.M. Gaya, J. Huguet, O. Rodriguez, J. Palou, and H. Villavicencio Can we identify those patients who will benefit from prostate-sparing surgery? Predictive factors for invasive prostatic involvement by transitional cell carcinoma Can J Urol 18 2011 5529 5536
40. D.L. Lamm, V.D. Stogdill, B.J. Stogdill, and R.G. Crispen Complications of bacillus Calmette-Guerin immunotherapy in 1,278 patients with bladder cancer J Urol 135 1986 272 274
41. P.F. Schellhammer, L.E. Ladaga, and R.P. Moriarty Intravesical bacillus Calmette-Guerin for the treatment of superficial transitional cell carcinoma of the prostatic urethra in association with carcinoma of the bladder J Urol 153 1995 53 56
42. H.W. Herr Carcinoma in situ of the bladder Semin Urol 1 1983 15 22
43. D.L. Lamm Bacillus Calmette-Guerin immunotherapy for bladder cancer J Urol 134 1985 40 47
44. J.B. deKernion, M.Y. Huang, A. Lindner, R.B. Smith, and J.J. Kaufman The management of superficial bladder tumors and carcinoma in situ with intravesical bacillus Calmette-Guerin J Urol 133 1985 598 601
45. A. Morales, D. Eidinger, and A.W. Bruce Intracavitary bacillus Calmette-Guerin in the treatment of superficial bladder tumors J Urol 116 1976 180 183
46. J. Palou, B. Xavier, P. Laguna, M. Montlleo, and J. Vicente In situ transitional cell carcinoma involvement of prostatic urethra: bacillus Calmette-Guerin therapy without previous transurethral resection of the prostate Urology 47 1996 482 484
47. J. Palou Redorta, P. Schatteman, and J. Huguet Pérez Intravesical instillations with bacillus Calmette-Guérin for the treatment of carcinoma in situ involving prostatic ducts Eur Urol 49 2006 834 838 discussion 838
48. E. Solsona, I. Iborra, J.V. Ricos, J.L. Monros, J.L. Casanova, and S. Almenar The prostate involvement as prognostic factor in patients with superficial bladder tumors J Urol 154 1995 1710 1713
49. P.J. Chibber, M.A. McIntyre, J.R. Hindmarsh, T.B. Hargreave, J.E. Newsam, and G.D. Chisholm Transitional cell carcinoma involving the prostate Br J Urol 53 1981 605 609
50. P.D. LaFontaine, B.R. Middleman, S.D. Graham Jr., and W.H. Sanders Incidence of granulomatous prostatitis and acid-fast bacilli after intravesical BCG therapy Urology 49 1997 363 366
51. E. Mukamel, M. Konichezky, D. Engelstein, S. Cytron, A. Abramovici, and C. Servadio Clinical and pathological findings in prostates following intravesical bacillus Calmette-Guerin instillations J Urol 144 1990 1399 1400
52. R.D. Oates, M.M. Stilmant, M.C. Freedlund, and M.B. Siroky Granulomatous prostatitis following bacillus Calmette-Guerin immunotherapy of bladder cancer J Urol 140 1988 751 754
53. O.N. Gofrit, D. Pode, G. Pizov, K.C. Zorn, R. Katz, and A. Shapiro Prostatic urothelial carcinoma: is transurethral prostatectomy necessary before bacillus Calmette-Guerin immunotherapy? BJU Int 103 2009 905 908
54. J.H. Taylor, J. Davis, and P. Schellhammer Long-term follow-up of intravesical bacillus Calmette-Guerin treatment for superficial transitional-cell carcinoma of the bladder involving the prostatic urethra Clin Genitourin Cancer 5 2007 386 389
55. D. Leibovici, A. Zisman, and Z. Chen-Levyi Elevated prostate specific antigen serum levels after intravesical instillation of bacillus Calmette-Guerin J Urol 164 2000 1546 1549
56. H. Lopez Llaurado, J. Palou Redorta, R. Montanes Bermudez, A.O. Samper, J.S. Bayarri, and H. Villavicencio Mavrich Changes in prostate specific antigen levels during intravesical instillations with Calmette-Guerin bacillus: relationship with transurethral resection of the prostate [in Spanish] Arch Esp Urol 56 2003 19 22
57. N. Sakamoto, M. Tsuneyoshi, S. Naito, and J. Kumazawa An adequate sampling of the prostate to identify prostatic involvement by urothelial carcinoma in bladder cancer patients J Urol 149 1993 318 321
58. H. Ovesen, A.L. Poulsen, and K. Steven Intravesical bacillus Calmette-Guerin with the Danish strain for treatment of carcinoma in situ of the bladder Br J Urol 72 1993 744 748
59. M.P. Revelo, M.S. Cookson, S.S. Chang, M.F. Shook, J.A. Smith Jr., and S.B. Shappell Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgery J Urol 171 2004 646 651
60. P.P. Dangle, M.C. Gong, R.R. Bahnson, and K.S. Pohar How do commonly performed lymphadenectomy templates influence bladder cancer nodal stage? J Urol 183 2010 499 503
61. N.J. Hellenthal, M.L. Ramirez, C.P. Evans, R.W.D. White, and T.M. Koppie Trends in pelvic lymphadenectomy at the time of radical cystectomy: 1988 to 2004 J Urol 181 2009 2490 2495
62. N.B. Dhar, E.A. Klein, A.M. Reuther, G.N. Thalmann, S. Madersbacher, and U.E. Studer Outcome after radical cystectomy with limited or extended pelvic lymph node dissection J Urol 179 2008 873 878
63. D.M. Schwalb, H.W. Herr, and W.R. Fair The management of clinically unconfirmed positive urinary cytology J Urol 150 1993 1751 1756
64. M.D. Schwalb, H.W. Herr, P.C. Sogani, P. Russo, J. Sheinfeld, and W.R. Fair Positive urinary cytology following a complete response to intravesical bacillus Calmette-Guerin therapy: pattern of recurrence J Urol 152 1994 382 387
65. A.G. Coutts, K.M. Grigor, and J.W. Fowler Urethral dysplasia and bladder cancer in cystectomy specimens Br J Urol 57 1985 535 541
66. B. Njinou Ngninkeu, F. Lorge, P. Moulin, J. Jamart, and P.J. Van Cangh Transitional cell carcinoma involving the prostate: a clinicopathological retrospective study of 76 cases J Urol 169 2003 149 152
67. J.H. Reese, F.S. Freiha, A.B. Gelb, B.L. Lum, and F.M. Torti Transitional cell carcinoma of the prostate in patients undergoing radical cystoprostatectomy J Urol 147 1992 92 95